{"url_path":"/sec/revb/8-k/2026-06-24/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1810560/0001193125-26-281200-index.html","accession_number":"0001193125-26-281200","cik":"0001810560","ticker":"REVB","issuer_name":"REVELATION BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1810560/0001193125-26-281200-index.html","primary_entity_key":"0001810560","primary_entity_name":"REVELATION BIOSCIENCES, INC."},"word_count":320,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nThe Company held an Annual Meeting of Stockholders (the “Annual Meeting”) on June 24, 2026. At the Annual Meeting of the Company, a total of 2,234,348 shares of the Company’s common stock, being greater than one-third of the 3,908,420 shares of common stock issued and outstanding and entitled to vote as of the record date for the Annual Meeting, were present virtually, or represented by valid proxy at the Annual Meeting, constituting a quorum.\n\nThe following proposals, each as described further in the definitive proxy statement filed with the Securities and Exchange Commission on May 11, 2026, were voted upon by the stockholders:\n\nProposal No. 1 – Election of Director\n\nStockholders elected Jennifer Carver, BSN, MBA as a Class A director to serve until the 2029 Annual Meeting or until her successor is duly elected and qualified, based on the votes listed below:\n\n \n\nFor\n\nAgainst\n\nWithheld\n\n519,169\n\n24,779\n\n263,081\n\n \n\nThere were 1,427,319 broker non-votes related to this proposal.\n\n \n\nProposal No. 2 – Authorization of Reverse Stock Splits\n\n \n\nStockholders approved a proposal to grant discretionary authority to the Company’s Board of Directors to effect one or more reverse stock splits of the Company’s common stock within one year of June 24, 2026, at a specific ratio of one-for-two to a maximum of one-for-250, with the specific ratio(s) to be fixed within this range by the Company’s Board of Directors in its sole discretion without further stockholder approval, based on the votes below:\n\nFor\n\nAgainst\n\nAbstain\n\n1,786,623\n\n444,315\n\n3,410\n\nThere were no broker non-votes regarding this proposal.\n\nProposal No. 3 – Ratification of Independent Registered Public Accounting Firm\n\nStockholders ratified the selection of Baker Tilly US, LLP to audit the Company’s financial statements for the fiscal year ending December 31, 2026, based on the votes listed below:\n\nFor\n\nAgainst\n\nAbstain\n\n1,794,221\n\n217,178\n\n222,949\n\nThere were no broker non-votes regarding this proposal."}